InvestorsHub Logo
Followers 231
Posts 34993
Boards Moderated 1
Alias Born 11/19/2003

Re: None

Wednesday, 09/30/2015 9:38:04 AM

Wednesday, September 30, 2015 9:38:04 AM

Post# of 335
Zafgen Granted Orphan Drug Designation in the European Union
for Beloranib, a First-in-Class MetAP2 Inhibitor for the Treatment of Craniopharyngioma

A fairly significant step.

http://finance.yahoo.com/news/zafgen-granted-orphan-drug-designation-110000884.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LRMR News